Dapsone syndrome in India.
D000328:Adult; D002648:Child; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects*; D003875:Drug Eruptions / Q000473:pathology; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D013577:Syndrome
D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin